We recently demonstrated that neoadjuvant RT of rectal adenocarcinoma patients leads to an increased expression in IFNβ and STING by cancer cells, in parallel with a restoration of the expression of HLA-class-I molecules [6]. This evidence concerns the gene STING1 and cancer.